Compare BTE & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTE | PBLS |
|---|---|---|
| Founded | 1993 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.6B |
| IPO Year | 2004 | 2026 |
| Metric | BTE | PBLS |
|---|---|---|
| Price | $4.57 | $33.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 14.3M | 576.5K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | ★ 1.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.93 | N/A |
| P/E Ratio | $18.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.18 | $25.56 |
| 52 Week High | $5.36 | $42.49 |
| Indicator | BTE | PBLS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 50.21 |
| Support Level | N/A | $37.77 |
| Resistance Level | N/A | $41.34 |
| Average True Range (ATR) | 0.00 | 2.60 |
| MACD | 0.00 | -0.24 |
| Stochastic Oscillator | 0.00 | 40.29 |
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.